Shriram General Insurance Exceeds Industry Performance Again in Q4: Reports 21 % Growth in Premium Income

▴ Mr. Anil Aggarwal, MD & CEO of Shriram General Insurance Company
Shriram General Insurance Company (SGI) reported a strong Q4FY26 performance, with Gross Direct Premium (GDP) rising 21% YoY to ₹1,332 Cr from ₹1,099 Cr, significantly ahead of the industry growth of 11%.
National, May 13, 2026: Shriram General Insurance Company (SGI) reported a strong Q4FY26 performance, with Gross Direct Premium (GDP) rising 21% YoY to ₹1,332 Cr from ₹1,099 Cr, significantly ahead of the industry growth of 11%. The growth was primarily driven by the company’s motor insurance portfolio.  For fiscal FY26 SGI’s GDP increased 24% to ₹4,636 crore from ₹3,753 Cr YoY –clocking 2.54 X the industry growth of 9% -reinforcing its position as one of the fastest-growing private general insurers in the country.
SGI’s Investment income rose by 22% in Q4 FY26 against 13% in Q4FY25.
SGI’s focus on profitable growth translated into a 28 % YoY increase in net profit, rising to ₹167Cr in Q4 FY26 from ₹130 Cr in the same period last year. For FY26 the net profit rose to Rs.601Cr from Rs.515 Cr - a 17 % increase from the previous year.
The Board approved final dividend payout of 53% taking the overall dividend payout for the fiscal@162%. For the previous year, SGI declared a total dividend of 140%.
The company continued to maintain a strong balance sheet, with a solvency ratio of 2.95 as of March 2026, above the regulatory requirement of 1.50.
Agent Network Expansion Drives Growth: SGI’s prudent phygital model remains a key enabler of its consistent growth. The company onboarded 19221 new financial advisors during FY26, an 18% increase over the previous year. The total advisor strength currently is 105675.
Branch network expanded to 289 from 279 a year ago, further strengthening its physical presence across geographies.
Active policies grew to 69 lakhs as of March 2026, compared to 65 lakhs in the previous year, reflecting deeper customer reach and sustained business momentum.
Segment wise GDP (in Rs. Cr)  
Particulars
Q4FY26
Q4FY25
Growth %
In FY26
In FY25
Growth %
Motor
1252.66
1031.17
21.48%
4293.01
3478.06
23.43%
Personal Accident
33.74
27.95
20.71%
139.95
119.49
17.13%
Fire
12.78
17.21
-25.76%
92.03
87.11
5.65%
Engineering
7.96
6.76
17.78%
29.06
24.10
20.59%
Health Insurance
9.89
1.58
524.82%
17.50
3.68
375.44%
Others Miscellaneous
14.63
14.43
1.42%
63.95
40.94
56.21%
Total
1332
1099
21.16%
4635.51
3753.38
23.50%
  
Mr. Anil Aggarwal, MD & CEO, Shriram General Insurance Company, said:
“Our FY26 performance reflects the strength of our business model and our focus on profitable and sustainable growth. Despite a competitive market environment, we outperformed the industry growth for the fourth consecutive year. Our motor portfolio remained key growth driver for the last quarter supported by disciplined underwriting, deeper distribution reach, and stronger claims servicing capabilities.”
New Product of the quarter:
Shri Health Suraksha 2.0: an enhanced indemnity-based health insurance plan offering all-inclusive protection with no room rent capping, unlimited restoration of sum insured, zero co-payment, and coverage for ambulance, air ambulance, consumables, and AYUSH treatments.
SGI’s next phase of Growth:
  • Distribution scale-up: SGI plans to expand its Financial Advisor network to 2 lakhs by FY 2029–30.
  • Growth targets: The company expects to close the next fiscal with ₹6000 Cr in GDP and reach ₹10,000 Cr by 2030.
  • Product diversification: SGI is exploring opportunities in parametric insurance and surety bond insurance
Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026
SIMS Hospital Treats Spinal Compression in 84-Year-Old with Pacemaker Through Single-Incision Endoscopic SurgeryJuly 15, 2026
Apollo Hospitals Secunderabad Successfully Treats Achalasia Cardia Patients with Advanced POEM ProcedureJuly 15, 2026
Happiest Health Announces Entry into Healthcare Publishing BusinessJuly 15, 2026
Indian Stroke Association Expands ‘Save the Brain’ Campaign with Stroke 360° Scientific Conference in SalemJuly 15, 2026
Milann Successfully Overcomes a Hidden Fertility Barrier: Chronic Endometritis Diagnosed and Treated, Leading to Successful IVF PregnancyJuly 15, 2026
Forus Health Launches FH eyepal, a Connected Digital Eye Clinic Designed to Expand Access to Comprehensive Eye CareJuly 15, 2026
Adult ADHD Diagnostics: Why Evaluations Are Rising Later in LifeJuly 15, 2026
Healthcare Apps Changing Patient Care: How Digital Health Tools Are Reshaping India's Healthcare LandscapeJuly 15, 2026
How Stress Affects Physical Health: Understanding the Body's Response and What You Can Do About ItJuly 15, 2026
Pediatric Immunity: Realities of Seasonal Vaccines & DevelopmentJuly 14, 2026
Hormonal Imbalances in Women: PCOS and Perimenopause July 14, 2026
Erectile Dysfunction and Overall Health: Why It Is a Signal, Not Just a SymptomJuly 14, 2026
PCOS and Fertility Connection: What Every Woman Trying to Conceive Should KnowJuly 14, 2026